Additional Information

Product Description

SYNVISC-ONE SYG 6 ML is a sterile, viscoelastic, and transparent gel-like solution used for the treatment of knee pain caused by osteoarthritis. This product is intended for use by healthcare professionals only and should not be self-administered.

The main active ingredient of SYNVISC-ONE SYG 6 ML is hyaluronan, a naturally occurring substance found in the synovial fluid of joints. The product is designed to mimic the natural properties of synovial fluid and provide cushioning and lubrication to the knee joint, thereby reducing pain and improving mobility.

Each pre-filled syringe of SYNVISC-ONE SYG 6 ML contains 6 milliliters of hyaluronan, and it is injected into the knee joint by a healthcare professional. The recommended dose is a single injection, which can provide up to six months of relief from osteoarthritis knee pain.

SYNVISC-ONE SYG 6 ML has been extensively studied and demonstrated to be a safe and effective treatment for osteoarthritis knee pain. It is approved by the U.S. Food and Drug Administration (FDA) and has been used by millions of patients worldwide.

In addition to its efficacy, SYNVISC-ONE SYG 6 ML is also highly tolerable, with a low incidence of side effects. Some common side effects may include mild pain, swelling, or stiffness at the injection site. These side effects are usually temporary and resolve on their own within a few days.

Overall, SYNVISC-ONE SYG 6 ML is an excellent treatment option for patients with osteoarthritis knee pain who have failed to respond to other conservative treatments. It offers significant pain relief, improved joint function, and a prolonged duration of effect, providing patients with an improved quality of life.